Výsledky vyhledávání - "Anurati Saha"

Prognostic value of the 6-gene OncoMasTR test in hormone receptor-positive HER2-negative early-stage breast cancer: Comparative analysis with standard clinicopathological factors

Publikováno v: European journal of cancer (Oxford, England : 1990). 152

The aim of the study was to assess the prognostic performance of a 6-gene molecular score (OncoMasTR Molecular Score [OMm]) and a composite risk score (OncoMasTR Risk Score [OM]) and to conduct a within-patient comparison against four routinely used

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64b6d60eb5c7a208e2276d96bf897889
https://pubmed.ncbi.nlm.nih.gov/34090143

Zobrazit plný text záznamu

Additional prognostic value of OncoMasTR multigene prognostic signature to clinicopathological information in patients with HR-positive, HER2-negative, lymph node-negative breast cancer from the TAILORx Tissue Bank, Ireland

Publikováno v: Journal of Clinical Oncology. 37:535-535

535 Background: Multigene prognostic signatures (MGPS) can identify early stage breast cancer patients who may require less aggressive treatment. To be clinically useful, MGPSs must provide additional prognostic information to clinicopathological inf

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c540df0563f78a7299e3bee76889b7c8
https://doi.org/10.1200/jco.2019.37.15_suppl.535

Zobrazit plný text záznamu

Chondrogenesis of embryonic limb bud cells in micromass culture progresses rapidly to hypertrophy and is modulated by hydrostatic pressure

Autor: Daniel J. Kelly, Anurati Saha, Rebecca A. Rolfe, Simon F. Carroll, Paula Murphy

Publikováno v: Cell and tissue research. 368(1)

Chondrogenesis in vivo is precisely controlled in time and space. The entire limb skeleton forms from cells at the core of the early limb bud that condense and undergo chondrogenic differentiation. Whether they form stable cartilage at the articular

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06aae46d506df4d6c53ebbcf95bccc7b
https://pubmed.ncbi.nlm.nih.gov/27770257

Zobrazit plný text záznamu

Comparison of the prognostic performance between OncoMasTR and OncotypeDX multigene signatures in hormone receptor-positive, HER2-negative, lymph node-negative breast cancer

Autor: Seodhna M. Lynch, Verena Amberger-Murphy, Joanna Fay, Katherine M. Sheehan, Niamh Russell, Anthony O'Grady, Stephen Barron, Darran P. O'Connor, Catherine M. Kelly, Bozena Fender, John Crown, Anurati Saha, Chan-Ju Angel Wang, Tony Loughman, Desmond O'Leary, Peter Dynoodt, Cesar Lopez Ruiz, William M. Gallagher

Publikováno v: Journal of Clinical Oncology. 36:12074-12074

12074Background: Multigene prognostic signatures (MGPS) enable identification of early stage breast cancer (BC) patients requiring less aggressive treatment. OncoMasTR is a new MGPS found via a nov...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e91cb8911a697453015b661891bbb939
https://doi.org/10.1200/jco.2018.36.15_suppl.12074

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání